Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/19/2025

Hypertension Management

Introduction to Hypertension Management

  • Hypertension management involves a combination of lifestyle modifications and pharmacotherapy, with the goal of reducing blood pressure and cardiovascular risk, as recommended by the American Heart Association and the American College of Cardiology 1, 2

First-Line Treatment

  • The American Heart Association recommends starting with an ACE inhibitor or ARB as first-line treatment for uncontrolled hypertension, with a target BP of <130/80 mmHg 1
  • The American College of Cardiology suggests considering an ACE inhibitor (e.g., lisinopril 10mg daily) or ARB as initial pharmacotherapy for hypertension 1
  • For patients with diabetes or chronic kidney disease (CKD), ACE inhibitor or ARB is preferred as initial therapy, according to the American Heart Association, with a high strength of evidence supporting this recommendation 1
  • For Black patients, the American Heart Association recommends calcium channel blocker or thiazide-like diuretic as initial therapy, with a moderate strength of evidence supporting this recommendation 1

Lifestyle Modifications

  • Intensive lifestyle modification combined with appropriate pharmacotherapy is the cornerstone of management for super morbidly obese patients with uncontrolled diabetes and hypertension, with metabolic surgery strongly recommended for those with BMI ≥40 kg/m² regardless of glycemic control, as recommended by the American Diabetes Association 2
  • Weight loss intervention should include structured programs with ≥16 sessions over 6 months focusing on diet, physical activity, and behavioral strategies to achieve a 500-750 kcal/day energy deficit, as suggested by the American Diabetes Association 2
  • A DASH-style eating pattern with reduced sodium (<2,300 mg/day), increased potassium, fruits (8-10 servings/day), vegetables, and low-fat dairy products (2-3 servings/day) is recommended for dietary approach, according to the American Diabetes Association 3, 4
  • At least 150 minutes of moderate-intensity aerobic activity per week is recommended for physical activity, as suggested by the American Diabetes Association 3

  • The following lifestyle modifications can lead to approximate reductions in systolic blood pressure:

    Modification Approximate Reduction in Systolic Blood Pressure
    Weight loss 5-20 mmHg per 10 kg lost
    DASH diet 8-14 mmHg
    Sodium reduction 2-8 mmHg
    Physical activity 4-9 mmHg
    Moderate alcohol consumption 2-4 mmHg [5, 6]

Pharmacotherapy

  • Metformin is recommended as first-line therapy as it promotes modest weight loss and improves glycemic control, although the citation is ignored, other sources from the American Diabetes Association suggest prioritizing medications associated with weight loss or weight neutrality, such as SGLT2 inhibitors, GLP-1 receptor agonists, amylin mimetics, and α-glucosidase inhibitors 2
  • Avoid or minimize insulin secretagogues, thiazolidinediones, and insulin as they are associated with weight gain, as recommended by the American Diabetes Association 2
  • ACE inhibitors or ARBs are preferred first-line options, reducing cardiovascular events, providing renoprotection, and improving insulin sensitivity, according to the American Diabetes Association, with a high strength of evidence supporting this recommendation 7, 8
  • Thiazide-like diuretics are an excellent alternative or add-on, with proven cardiovascular event reduction, as recommended by the American Diabetes Association, with a moderate to high strength of evidence supporting this recommendation 7
  • Dihydropyridine calcium channel blockers are an alternative or add-on, with effective blood pressure reduction and minimal metabolic effects, according to the American Diabetes Association, with a moderate strength of evidence supporting this recommendation 7
  • SGLT2 inhibitors have modest BP-lowering effects and cardiovascular benefits, but are primarily indicated for diabetes management, making them less appropriate as a primary antihypertensive choice for patients with pre-diabetes, with a low to moderate strength of evidence supporting this recommendation 9

Metabolic Surgery

  • Metabolic surgery is strongly recommended for patients with BMI ≥40 kg/m² regardless of glycemic control level or medication regimen, and should be considered for patients with BMI 35.0-39.9 kg/m² if hyperglycemia is inadequately controlled despite lifestyle and optimal medical therapy, as recommended by the American Diabetes Association 2
  • Surgery should be performed in high-volume centers with multidisciplinary teams, and is appropriate for patients with BMI ≥27 kg/m² with obesity-associated comorbidities, as suggested by the American Diabetes Association 2

Monitoring and Follow-up

  • Home BP monitoring is recommended to document blood pressure for medication titration, according to the American Heart Association and the American College of Cardiology, with a high strength of evidence supporting this recommendation 10
  • Automated validated devices are recommended for blood pressure measurement, with the device having an appropriate cuff size, and patients sitting quietly for 5 minutes before measurement, avoiding caffeine, exercise, and smoking for at least 30 minutes prior, emptying their bladder before measurement, and sitting with their back supported and feet flat on the floor, as recommended by the American Heart Association, with a moderate to high strength of evidence supporting this recommendation 11
  • Follow-up appointments should be scheduled within 1 month for patients with BP 130-139/80-89 mmHg, within 2-4 weeks for patients with BP 140-159/90-99 mmHg, and within 1-2 weeks for patients with BP ≥160/100 mmHg, as recommended by the American College of Physicians, with laboratory monitoring, including serum creatinine, eGFR, and potassium, performed within 2-4 weeks of starting therapy with ACE inhibitors, ARBs, or diuretics, as recommended by the American Diabetes Association, with a moderate strength of evidence supporting this recommendation 12, 13

Patient Education and Prevention

  • Hypertension education should include disease process and cardiovascular risk, importance of medication adherence, and recognition of symptoms requiring medical attention, as recommended by the American Heart Association, with a moderate strength of evidence supporting this recommendation 1
  • Immunization recommendations include influenza and pneumococcal vaccinations, according to the American Heart Association, with a high strength of evidence supporting this recommendation 1

REFERENCES

← Return to Home